Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryoport (CYRX) Cost of Revenue (2016 - 2025)

Cryoport (CYRX) has disclosed Cost of Revenue for 14 consecutive years, with $23.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 352.78% to $23.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $93.1 million, a 67.0% increase, with the full-year FY2025 number at $93.1 million, up 6.9% from a year prior.
  • Cost of Revenue was $23.7 million for Q4 2025 at Cryoport, up from $22.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $35.7 million in Q1 2023 to a low of -$9.4 million in Q4 2024.
  • A 5-year average of $25.1 million and a median of $29.3 million in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: skyrocketed 801.17% in 2021, then crashed 119.35% in 2023.
  • Cryoport's Cost of Revenue stood at $33.3 million in 2021, then grew by 2.26% to $34.1 million in 2022, then plummeted by 119.35% to -$6.6 million in 2023, then tumbled by 42.4% to -$9.4 million in 2024, then surged by 352.78% to $23.7 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Cost of Revenue are $23.7 million (Q4 2025), $22.9 million (Q3 2025), and $24.1 million (Q2 2025).